← Open Payments lookup

KAMRON FARIBA: Open Payments

NPI 1407315864 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$879 in 34 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $879

Food & beverage: $770Education: $109
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$195
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$158
Teva Pharmaceuticals USA, Inc.4$144
Alkermes, Inc.1$122
Neurocrine BioSciences, Inc.2$66
Janssen Pharmaceuticals, Inc3$54
E.R. Squibb & Sons, L.L.C.2$42
ABBVIE INC.2$33
Indivior Inc.1$26
Axsome Therapeutics, Inc.1$25

Products named: REXULTI, CAPLYTA, LYBALVI, INGREZZA, INVEGA SUSTENNA, COBENFY, VRAYLAR, SUBLOCADE.

Industry payments across CA — which companies pay providers there.